CytoReason is an AI company developing a computational model of the human body, accurate enough to replace animal and human trials in drug development. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led biological discovery platform, pharma and biotech companies speed up drug discovery and dramatically cut the cost of developing new medicines. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
Menachem Begin, 132 Tel Aviv
